India Diclofenac Sodium Market By Product Type (Prescription v/s OTC), By Form (Tablet, Injection, Gel, Others), By Application (Osteoarthritis, Ankylosing Spondylitis, Dysmenorrhea, Rheumatoid arthritis, Migraine, Pain and Others), By Route of Administration (Oral, Intravenous, Topical, Others), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By End User (Adult v/s Paediatric), By Region, Competition, Forecast & Opportunities, 2021-2031F

Market Overview

India Diclofenac Sodium Market was valued at USD 312.43 Million in 2025 and is expected to reach USD 398.41 Million by 2031, growing with a CAGR of 4.27% in the forecast period.  

The India diclofenac sodium market has shown steady growth over the years, driven by increasing cases of musculoskeletal disorders such as arthritis, osteoarthritis, and spondylitis. Diclofenac sodium, a non-steroidal anti-inflammatory drug (NSAID), is widely used in India for its potent analgesic and anti-inflammatory properties. The demand for this drug is particularly high among the elderly population, which is steadily increasing in the country. Moreover, the growing awareness of pain management and the expanding reach of pharmaceutical companies into rural and semi-urban areas are further fueling market growth.

India is a significant producer and exporter of generic drugs, including diclofenac sodium formulations and active pharmaceutical ingredients (APIs). The country's cost-effective manufacturing capabilities and a strong network of domestic and multinational pharmaceutical firms contribute to its leadership in the global diclofenac market. Additionally, the government's efforts to increase access to affordable medicines through schemes like Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) have boosted the availability of diclofenac sodium at subsidized rates in various parts of the country.

Key Market Drivers

Rising Prevalence of Musculoskeletal Disorders

The rising prevalence of musculoskeletal disorders is a major driver of the diclofenac sodium market in India. Conditions such as arthritis, osteoarthritis, rheumatoid arthritis, and spondylitis are increasingly common among the Indian population, impacting both the elderly and younger age groups. These disorders often cause chronic pain, inflammation, and mobility issues, leading to a growing demand for effective pain management solutions. Diclofenac sodium, a widely used non-steroidal anti-inflammatory drug (NSAID), plays a central role in providing relief from these symptoms.

In India, changes in lifestyle, sedentary work environments, and limited physical activity have contributed to an increase in joint and muscle-related disorders, even among younger populations. The country is also witnessing a growing number of injuries due to road accidents, sports activities, and occupational hazards, all of which require effective anti-inflammatory treatments. As a result, healthcare providers frequently prescribe diclofenac sodium to manage pain and reduce inflammation in musculoskeletal conditions.

The burden of osteoarthritis and lower back pain is particularly high among the aging population. As this demographic continues to grow, so does the need for long-term medication that helps improve quality of life and daily functioning. Diclofenac sodium is often used in both acute and chronic treatment regimens, making it a go-to choice for patients and physicians alike.

Increased awareness of these disorders and improved access to healthcare services have led to earlier diagnosis and higher treatment rates. Patients are now more inclined to seek medical intervention for musculoskeletal pain, driving the demand for affordable and accessible medications. Diclofenac sodium, available in various formulations such as tablets, gels, and injections, meets the needs of diverse patient groups. This sustained demand supports the continued growth of the diclofenac sodium market in India as musculoskeletal disorders become a pressing public health concern.

Growing Geriatric Population

The growing geriatric population in India is a key factor contributing to the expansion of the diclofenac sodium market. As life expectancy increases and healthcare access improves, the number of elderly individuals in the country continues to rise. This demographic shift brings with it a higher incidence of age-related health conditions, particularly those involving pain and inflammation. Disorders such as osteoarthritis, rheumatoid arthritis, and chronic back pain are especially common among older adults, leading to increased reliance on medications like diclofenac sodium.

Elderly individuals often experience degenerative changes in bones and joints, making them more susceptible to musculoskeletal disorders. These conditions result in persistent pain, swelling, and limited mobility, which significantly impact daily life. Diclofenac sodium, known for its anti-inflammatory and analgesic properties, is frequently prescribed to manage such symptoms effectively. The drug is used not only in long-term treatment plans but also for acute flare-ups that affect the elderly disproportionately.

The geriatric population typically requires medications that are affordable, easily available, and well-tolerated. Diclofenac sodium is available in multiple forms, such as tablets, topical gels, and injections, allowing flexibility in administration based on patient condition and severity of pain. Its cost-effectiveness and wide availability in both rural and urban areas make it a preferred choice for managing age-related pain conditions.

With India’s senior citizen population projected to grow substantially in the coming years, healthcare systems are increasingly focused on managing chronic illnesses that affect this group. Pain management remains a top priority, and the role of anti-inflammatory drugs like diclofenac sodium is central to improving the quality of life for older adults. The consistent demand generated by this aging segment ensures a strong and stable market for diclofenac sodium across both prescription and over-the-counter channels.

Expansion of Retail Pharmacies and E-Pharmacies

The expansion of retail pharmacies and e-pharmacies across India has significantly influenced the growth of the diclofenac sodium market. As accessibility to medicines improves through these channels, consumers are finding it easier to obtain essential drugs, including pain relievers like diclofenac sodium. Traditional pharmacies have become more widespread in Tier 2 and Tier 3 cities, as well as in rural areas, where healthcare infrastructure was previously limited. These physical outlets ensure that commonly used drugs, including non-steroidal anti-inflammatory drugs (NSAIDs), are within reach of a broader population.

In parallel, the rise of e-pharmacies has transformed how medications are purchased, offering convenience, competitive pricing, and home delivery services. Consumers can now easily order diclofenac sodium in various forms—such as tablets, gels, or sprays—without needing to travel to a store. E-pharmacies have also played a key role in educating users about drug usage, side effects, and alternative options through online platforms, enhancing awareness and responsible consumption.

Retail and online pharmacies often provide both branded and generic versions of diclofenac sodium, giving consumers a range of choices based on price and preference. Discounted prices and promotional offers commonly seen on e-pharmacy platforms also contribute to increased sales volume. The ease of obtaining over-the-counter formulations of diclofenac sodium, especially topical applications for joint and muscle pain, has led to a surge in demand from individuals seeking quick and effective relief. As more pharmacy chains and digital health platforms establish a presence across the country, the availability and distribution of diclofenac sodium continue to improve. This growth in retail and digital pharmacy networks ensures a reliable supply chain for the drug, reducing stockouts and improving treatment continuity. The combined effect of physical reach and digital convenience strengthens the market potential for diclofenac sodium in India.

Download Free Sample Report

Key Market Challenges

Environmental and Ecological Concerns

Environmental and ecological concerns present a serious challenge to the diclofenac sodium market in India. One of the most widely recognized issues is the drug’s impact on the vulture population. Diclofenac, when used in veterinary medicine, enters the environment through livestock carcasses. Vultures that feed on these carcasses often suffer fatal kidney failure after ingesting the drug. This has led to a sharp decline in vulture numbers, disrupting the natural scavenging system and leading to broader ecological consequences.

In response to this crisis, the Indian government banned the veterinary use of diclofenac and promoted safer alternatives for animal treatment. Despite these regulations, illegal use still occurs in some regions, raising concerns about enforcement and compliance. Environmental advocacy groups continue to push for stricter controls and broader awareness campaigns to curb the misuse of diclofenac in animals.

For the human pharmaceutical market, this ecological issue indirectly influences public perception and regulatory scrutiny. Manufacturers and healthcare providers are increasingly pressured to ensure responsible production and distribution practices. These environmental concerns have led to more cautious use of the drug and closer monitoring of its impact beyond human health.

Pharmaceutical companies operating in this space must also invest in environmentally responsible waste disposal systems to prevent contamination of water bodies and soil. The growing emphasis on environmental sustainability is shaping how diclofenac sodium products are formulated, marketed, and regulated. As awareness of ecological impact deepens, the industry is required to balance therapeutic demand with long-term environmental stewardship, making sustainability a key component of future market strategy.

Side Effects and Safety Issues

Side effects and safety issues pose a significant challenge to the growth of the diclofenac sodium market in India. While the drug is widely used for its anti-inflammatory and pain-relieving properties, its long-term use has raised concerns among healthcare professionals. Diclofenac sodium is known to cause gastrointestinal problems such as ulcers, bleeding, and stomach pain, especially when taken without proper medical supervision. These side effects are more pronounced in elderly patients, who form a large segment of the drug’s user base.

Cardiovascular risks are another major concern. Studies have shown that prolonged use of diclofenac can increase the risk of heart attack and stroke, particularly at higher doses. This has led physicians to be more cautious when prescribing the drug to patients with pre-existing heart conditions or those at higher cardiovascular risk. Such caution often results in reduced prescriptions or a preference for alternative medications with a better safety profile.

Liver and kidney toxicity is also associated with long-term diclofenac use. These risks require regular monitoring of liver and renal function in patients on extended treatment plans, increasing the overall cost and complexity of care. For patients, the need for regular follow-ups and lab tests can reduce adherence to treatment. Self-medication is common in India, and diclofenac sodium is often used without medical guidance. This unregulated consumption heightens the risk of adverse effects, particularly when patients are unaware of dosage limits or contraindications. These safety concerns continue to influence regulatory actions, public perception, and physician prescribing habits in the Indian market.

Key Market Trends

Growth of Online Pharmacies

The growth of online pharmacies in India is reshaping the distribution and accessibility of diclofenac sodium, both in oral and topical forms. As internet penetration and smartphone usage increase across urban and semi-urban regions, consumers are turning to digital platforms for healthcare needs. E-pharmacies provide a convenient solution for purchasing over-the-counter and prescription medications, including pain relief drugs like diclofenac sodium, without the need to visit physical stores.

This trend has expanded access to diclofenac products, especially in areas with limited pharmacy infrastructure. Online platforms often offer competitive pricing, discounts, and door-to-door delivery, making it easier for patients to maintain a consistent supply of pain relief medications. The convenience of comparing brands, reading product reviews, and checking availability in real time has made online pharmacies a preferred option for many.

E-pharmacies also help improve compliance and awareness by providing information about proper dosage, possible side effects, and drug interactions. For patients with chronic pain conditions who require regular use of diclofenac, subscription models and automated refill services ensure timely access to medication.

Pharmaceutical companies are increasingly partnering with digital platforms to boost the visibility of their products and reach a broader audience. Topical formulations of diclofenac, in particular, have gained popularity online due to their non-prescription status and ease of use. The rapid expansion of e-pharmacies is expected to continue, supported by digital healthcare adoption and consumer preference for contactless services. This shift enhances the distribution network for diclofenac sodium and supports sustained market growth across India.

Shift Toward Topical Formulations

The Indian diclofenac sodium market is witnessing a noticeable shift toward topical formulations. This trend is driven by growing awareness of the side effects associated with oral NSAIDs, such as gastrointestinal irritation, liver toxicity, and cardiovascular risks. Topical products like gels, sprays, and patches offer localized pain relief with minimal systemic absorption, making them a safer alternative for long-term or frequent use.

Patients suffering from joint pain, muscle strains, and mild arthritis symptoms often prefer topical diclofenac for its fast action and ease of application. These formulations are especially popular among the elderly, who may have comorbid conditions that make oral NSAIDs risky. By applying the medication directly to the affected area, users can experience targeted relief without exposing their entire system to the drug. Pharmaceutical companies are responding to this demand by expanding their range of topical diclofenac products. Innovations in formulation technology have led to faster-absorbing, longer-lasting, and more user-friendly applications. These products are now available in various packaging formats such as tubes, roll-ons, and spray bottles, catering to diverse consumer preferences.

Retail and e-pharmacies are playing a crucial role in promoting these formulations. The visibility of topical options on shelves and online platforms has increased consumer familiarity and trust. Marketing campaigns often highlight the safety and convenience of topical use, reinforcing the shift in consumer behavior. As awareness of potential side effects of oral diclofenac grows, the preference for topical treatments is expected to continue rising, positioning these formulations as a major driver of future market growth in India.

Segmental Insights

Product Type Insights

Based on product type, in the Indian diclofenac sodium market, Over-the-Counter (OTC) usage is more dominant than prescription-based consumption. Diclofenac is widely available in topical forms such as gels, sprays, and ointments, which do not require a prescription and are commonly used for self-treatment of joint, muscle, and back pain. The affordability, easy access through retail and online pharmacies, and immediate pain relief it offers have made it a go-to solution for a wide range of consumers.

Cultural habits of self-medication and limited access to healthcare professionals in rural or semi-urban areas also contribute to the higher OTC usage. Consumers often rely on local pharmacists or personal experience rather than consulting a physician. Oral diclofenac tablets are also sometimes purchased without prescriptions despite regulatory guidelines, adding to the OTC volume. While prescription use exists for chronic or severe conditions, the convenience and perceived safety of topical OTC formulations drive the bulk of market demand.

Form Insights

Based on form, In the Indian diclofenac sodium market, tablets represent the fastest growing segment. Their widespread use is fueled by their effectiveness in treating a broad range of conditions involving moderate to severe pain, including arthritis, musculoskeletal disorders, dental pain, and post-operative inflammation. Tablets are cost-effective, easy to store and transport, and provide systemic relief, making them suitable for both acute and chronic pain management.

This growth is supported by high patient familiarity, frequent physician prescriptions, and strong availability across both retail and online pharmacies. Additionally, many patients prefer tablets for their convenience and often purchase them over the counter, despite prescription guidelines for certain strengths. While other formulations like gels, injections, sprays, and patches are also present, tablets continue to expand their market share due to affordability, broad applicability, and user preference.

Download Free Sample Report

Regional Insights

Based on region, North India dominated the diclofenac sodium market in India due to a combination of demographic, healthcare, and industrial factors. The region includes highly populated states such as Uttar Pradesh, Punjab, Haryana, Delhi, and Rajasthan, where the burden of musculoskeletal disorders, arthritis, and joint pain is significant. A large aging population, coupled with a high incidence of physical labor-intensive occupations, contributes to increased demand for pain relief medications like diclofenac sodium. North India has a well-established healthcare infrastructure, with numerous government and private hospitals, clinics, and pharmacies that support the widespread distribution and consumption of both prescription and OTC diclofenac products. The region is also a hub for pharmaceutical manufacturing and distribution, particularly in cities like Baddi in Himachal Pradesh, which boosts supply chain efficiency. The availability of diclofenac in multiple forms—tablets, gels, and injections—through both physical and online pharmacies enhances access across urban and rural areas. Strong awareness among healthcare providers and consumers further supports its widespread usage, positioning North India as the leading regional market for diclofenac sodium.

Key Market Players

• Novartis India Ltd.
• Hetero Drugs Ltd.
• Auro Laboratories Ltd.
• Aarti Drugs Ltd.
• J B Chemicals and Pharmaceuticals Ltd.
• Novartis India Ltd.
• Emkay Pharma Pvt. Ltd.
• Bestochem Formulations (India) Limited
• Salvavidas Pharmaceutical Pvt. Ltd.
• Wellona Pharma Pvt. Ltd.

Report Scope:

In this report, the India Diclofenac Sodium Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• India Diclofenac Sodium Market, By Product Type:

o   Prescription

o   OTC      

• India Diclofenac Sodium Market, By Form:

o   Tablet

o   Injection

o   Gel

o   Others      

• India Diclofenac Sodium Market, By Application:

o   Osteoarthritis

o   Ankylosing Spondylitis

o   Dysmenorrhea

o   Rheumatoid arthritis

o   Migraine

o   Pain

o   Others       

• India Diclofenac Sodium Market, By Route of Administration:

o   Oral

o   Intravenous

o   Topical

o   Others      

• India Diclofenac Sodium Market, By Source:

o   In-house

o   Contract Manufacturing Organizations

• India Diclofenac Sodium Market, By Distribution Channel:

o   Online

o   Offline    

• India Diclofenac Sodium Market, By End User:

o   Adult

o   Paediatric

• India Diclofenac Sodium Market, By Region:

o   North India

o   East India

o   West India

o   South India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the India Diclofenac Sodium Market.

Available Customizations:

India Diclofenac Sodium Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).